Table S4.

Data Abstraction table B: Treatment outcomes (48 data sets).

Reference numbers	Sample size of treated pan susceptible pulmonary TB and all forms of resistance except MDR-TB (N)	N treated with each regimen	Treatment outcomes					Remarks
			Completed				Not completed
			Success (cured and completed)	Failed	Died	Relapsed	Defaulted
[1]	105	57	25	7	7	1	18	Total on FDC 57
		48	25	4	2	0	16	Total on separate formulation 48
[2]	67	67	58	3	0	6	0	67 patients on 2EHRZ/4RH
[3]	1355	456	231	47	17	20	74	The study included some HIV positives.
		466	248	32	9	30	89
		433	249	36	12	9	74
[4]	146	39	39	0	0	0	0
[5]	1585	798	591	19	8	48	9	39 on FDC and 38 patients on separate drugs were HIV positive.
		787	589	16	8	42	1
[6]	837	415	347	32	26	0	27
		422	320	27	21	0	55
[7]	198	198	193	0	0	4	0	67 of 198 patients were smear negative
[8]	360	162	152	5	2	0	2	Two patients on NTP regimen excluded due jaundice are reflected under TO
		198	188	8	3	0	1
[9]	520	175	171	2	1	1	0
		174	171	1	1	2	0
		171	161	3	3	2	0
[10]	100	34	26	2	0	0	4
		34	26	0	0	0	6
		32	24	2	0	0	6
[11]	122	61	44	4	2	0	5
		61	53	2	0	0	4
[12]	141	141	127	0	1	4	0
[13]	1159	582	468	24	11	7	43	FDC
		577	477	16	4	4	41	ST
[14]	467	450	393	33	4	20	0
[15]	825	305	279	11	0	15	0	112 patients excluded due to ineligibility
		263	234	1	0	28	0
[16]	170	165	144	5	1	10	2
[17]	497	170	113	7	6	0	46
		165	103	7	7	0	53
		162	105	3	3	0	53
[18]	434	236	208	12	3	10	4	FDC-119 have no bacteriological follow up data
		198	179	7	3	2	4	Loose drugs-108 have no bacteriological follow up data
[19]	168	61	61	6	0	0	0	Detailed outcomes not given for all patients by regimen
		58	58	20	0	0	0
[20]	1240	407	338	37	0	32	0	A third of included in the analysis were previously treated.
		415	363	26	0	26	0
		418	334	48	0	36	0
[21]	188	188	171	5	0	10	2
[22]	399	199	193	1	0	5	0	64 of drug sensitive and 13 of drug resistant had previous chemotherapy
		200	199	0	0	1	0
[23]	98	87	86	1	0	0	0	32 patients were HIV positive
[24]	88	88	87	0	0	1	0
[25]	156	156	106	12	2	4	12	Rifampicin group
	142	142	102	5	2	5	12	Rifabutin group
[26]	102	102	97	1	0	4	0
[27]	67	67	67	0	0	0	0